News Daily News FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen Michael O'Riordan April 25, 2018
News Daily News Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib Todd Neale April 24, 2018
News Daily News FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled Michael O'Riordan April 24, 2018
News Daily News Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes Shelley Wood April 18, 2018
Podcast TCTMD Talking Points CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock April 18, 2018
Presentation Preangioplasty iFR Pullback Predicts Hemodynamic Outcome in CAD: iFR GRADIENT Registry April 17, 2018
News Daily News Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins Michael O'Riordan April 16, 2018
Presentation Fellows 2018 ACS Pharmacology for the Interventionalist Presenter: Duane S. Pinto, Gregg W. Stone April 13, 2018
News Daily News Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows Michael O'Riordan April 05, 2018
News Daily News Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI Yael L. Maxwell April 04, 2018
News Daily News Time for Guidelines to Recommend ARBs Over ACE Inhibitors? Shelley Wood March 29, 2018
News Features ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging Michael O'Riordan March 23, 2018
Presentation CIT 2018 Optimal Pharmacology and PCI Strategy in STEMI & Multivessel Disease Presenter: Ran Kornowski March 23, 2018
Podcast TCTMD Talking Points VAMPIRE 3: A Randomized Trial of Distal Filter Protection During PCI of High-Risk Plaque March 21, 2018
News Conference News ACC 2018 High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab Michael O'Riordan March 20, 2018
News Conference News ACC 2018 Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4 Yael L. Maxwell March 19, 2018
News Conference News ACC 2018 PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats Yael L. Maxwell March 14, 2018